Solid Form Informatics for Pharmaceuticals and Fine Chemicals

Solid form informatics (SFI) provides a knowledge-based approach to improve the effectiveness and quality of early-phase drug discovery research, as well as a rational approach to risk assessment. 

SFI makes use of the wide coverage of pharmaceutical compounds in corporate and public crystal structural databases, permitting the development and use of predictive analytics for solid forms accelerating the drug discovery process. 

Download this whitepaper to discover the benefits of adopting SFI such as:

• More comprehensive screenings at a reduced cost 
• Independent, knowledge-based risk assessments 
• The ability to identify potential issues for manufacturing in the early stages of development